1.
Advances of a new inhibitor of tumor angiogenesis:hexastatin
新型肿瘤血管生成抑制剂hexastatin的研究进展
2.
Investigation of an Evaluative Experimental Scheme of Anti-angiogenic Therapy
建立肿瘤血管生成抑制剂的体外筛选方法
3.
Experimental study of angiogenesis inhibitor TNP-470 on suppression of tumour growth and microvascular angiogenesis;
血管形成抑制剂TNP-470抑制肿瘤生长和微血管形成的实验研究
4.
Study on Vasostatin Protein Preparation and Anti-tumor Mechanism;
血管生成抑制剂Vasostatin蛋白的制备和抗肿瘤研究
5.
Inhibition of angiogenesis can suppress tumor growth.
通过抑制肿瘤相关的血管生成可以抑制肿瘤的生长。
6.
Study on the Mechanism of Angiostatin in Antiangiogenesis of Tumor;
血管抑素抗肿瘤血管生成机制的实验研究
7.
NUMERICAL SIMULATION OF INHIBITORY EFFECTS OF ENDOSTATIN ON TUMOR ANGIOGENESIS
内皮抑素抑制肿瘤血管生成的数值模拟
8.
Inhibitory Effect and Mechanism of Endostatin on the Angiogenesis of Xenografted Namalwa Lymphoma in Nude Mice
内皮抑素抑制Namalwa淋巴瘤裸鼠移植瘤肿瘤血管生成的作用及其机制
9.
Study on the Inhibition by the Medicated Serum with Scutellariabarbatae D.Don of Cancer Angiogenesis;
半枝莲含药血清抑制肿瘤血管生成的实验研究
10.
In Vitro Antiangiogenic Activity of Salvicine;
Salvicine抑制肿瘤新生血管生成及其机制的研究
11.
Experimental Approach for Suppression of Neovascularization of Carcinoma by Mutouhui (Diversifolious Patrinia Root);
“墓头回”活性成份抑制肿瘤血管生成的实验研究
12.
Survey on the Research of Endogenous Blood Vessel Producing Inhibitors in Tumor;
内源性肿瘤血管生成抑制物作用机制研究综述
13.
Inhibitory effect of arsenic trioxide on tumor growth and angiogenesis in nude mice bearing transplanted tumor
As_2O_3对裸鼠移植肿瘤生长及血管生成的抑制作用
14.
The Study of Inducing Apoptosis of Tumor Cell and Inhibition of Tumor Angiogenesis by Celastrus Orbiculatus
南蛇藤总萜诱导肿瘤细胞凋亡及抑制肿瘤血管生成的实验研究
15.
Study on the Inhibition by the Abstracts of Scutellariabarbatae D.Don of Cancer Angiogenesis;
半枝莲提取物抑制肿瘤血管生成的实验研究
16.
Studies on Antiangiogenesis of MD Tumor Induced by Arsenic Trioxide;
三氧化二砷抑制鸡MD肿瘤血管生成的研究
17.
Experimental Study of the Inhibitory Effect of Rapamycin on Angiogenesis Induced by Hepatocellular Carcinoma;
雷帕霉素抑制肝癌肿瘤血管生成的实验研究
18.
Two angiogenesis inhibitors have been developed that have a broad spectrum of anticancer activity, yet virtually no side effects.
目前，已有两种具有广谱抗肿瘤活性且无明显副作用的血管生成抑制剂面世。